A detailed history of Wealthspire Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 11,917 shares of EW stock, worth $1.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,917
Previous 12,812 6.99%
Holding current value
$1.09 Million
Previous $976,000 16.6%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$72.54 - $95.56 $64,923 - $85,526
-895 Reduced 6.99%
11,917 $1.14 Million
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $24,252 - $30,559
393 Added 3.16%
12,812 $976,000
Q3 2023

Nov 06, 2023

BUY
$69.28 - $93.38 $860,388 - $1.16 Million
12,419 New
12,419 $860,000
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $213,369 - $273,162
3,124 New
3,124 $233,000
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $245,111 - $308,529
-2,404 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $31,911 - $39,204
300 Added 14.26%
2,404 $311,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $216,522 - $258,266
2,104 New
2,104 $238,000
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $713,226 - $891,193
-8,507 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $92,763 - $106,899
1,179 Added 16.09%
8,507 $712,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $158,219 - $201,344
2,207 Added 43.1%
7,328 $669,000
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $15,588 - $20,286
232 Added 4.75%
5,121 $409,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $75,837 - $101,420
1,318 Added 36.91%
4,889 $338,000
Q1 2020

May 12, 2020

BUY
$52.41 - $81.0 $187,156 - $289,251
3,571 New
3,571 $674,000
Q1 2019

May 08, 2019

SELL
$47.89 - $64.05 $7,997 - $10,696
-167 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $7,750 - $9,508
167 New
167 $26,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wealthspire Advisors, LLC Portfolio

Follow Wealthspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.